Skip to main navigation Skip to search Skip to main content

Lecanemab approval in EU: what should we be ready for?– the EANM perspective

  • Igor Yakushev
  • , Antoine Verger
  • , Matthias Brendel
  • , Diego Cecchin
  • , Pablo Aguiar Fernandez
  • , Francesco Fraioli
  • , Timo Grimmer
  • , Nelleke Tolboom
  • , Tatjana Traub-Weidinger
  • , Eric Guedj
  • , Donatienne Van Weehaeghe
  • Technical University of Munich
  • LORIA, UMR 7503, University of Lorraine
  • Ludwig-Maximilians-Universität München
  • University Hospital Padua
  • University of Santiago de Compostela
  • University College London
  • University Medical Center Utrecht
  • Vienna Healthcare Group
  • UMR 7249
  • Ghent University Hospital

Research output: Contribution to journalEditorial

11 Scopus citations
Original languageEnglish
Pages (from-to)1607-1610
Number of pages4
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume52
Issue number5
DOIs
StatePublished - Apr 2025

Cite this